Section Arrow
UPB.NASDAQ
- Upstream Bio Inc
Quotes are at least 15-min delayed:2025/11/19 03:46 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours
Last
 25.56
-0.14 (-0.54%)
Day High 
26.2 
Prev. Close
25.7 
1-M High
26.9 
Volume 
585.00K 
Bid
--
Ask
--
Day Low
25.07 
Open
26.2 
1-M Low
21.02 
Market Cap 
1.39B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 24.02 
20-SMA 23.85 
50-SMA 20.63 
52-W High 26.9 
52-W Low 5.14 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-6.40/-2.64
Enterprise Value
1.39B
Balance Sheet
Book Value Per Share
7.01
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.21M
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CANFCan-Fite BioPharma Ltd0.3801+0.0181+5.00%-- 
Pre Market -- -- --
ASBPAspire Biopharma Holdings Inc.0.1057+0.0144+15.77%-- 
Pre Market -- -- --
OLMAOlema Pharmaceuticals20.14+11.62+136.38%-- 
Pre Market -- -- --
CMNDClearmind Medicine0.2164-0.0605-21.85%0.16PE
Pre Market -- -- --
APLTApplied Therapeutics0.2984+0.0142+5.00%-- 
Pre Market -- -- --
Quotes are at least 15-min delayed:2025/11/19 03:46 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Upstream Bio Inc is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It is developing verekitug, the known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin (TSLP), a cytokine that is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune-mediated diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.